. without diagnosis and within 3 yr had become Many patients with this disease are shown to have housebound. Osteomalacia was finally diagnosed in benign tumours of mesenchymal origin with prominent 1965, when she fractured both arms whilst lifting her fibrous and vascular characteristics [3, 4] . Cure is genernewborn baby and radiographs disclosed eight separate ally expected to follow surgical resection, with return of sites of previous fracture. She was treated with calciferol phosphate and 1,25(OH ) 2 D levels to normal [3] [4] [5] , 50 000 i.u. daily and within 3 yr her symptoms had indicating a likely causal relationship between tumour resolved. In 1970 a cystic 4-inch swelling overlying the and both hypophosphataemia and 1,25(OH ) 2 D producleft scapula was removed, the histology being reported tion. Furthermore, experimental evidence supports a as a cystic lymphangioma. She then discontinued calcirole for tumour products which influence both renal ferol, but in 1973 relapsed with widespread skeletal tubular cell phosphate transport and 1a-hydroxylase pains, weakness and fatigue. activity [6] [7] [8] [9] . The term 'oncogenic hypophosphataemic On referral, she had a proximal myopathy, being osteomalacia' (OHO) is now applied to this group. unable to rise from a chair. A small, firm, non-tender, OHO was first recognized over 40 yr ago [10] .
non-fixed periscapular mass was identified. General However, despite its musculoskeletal symptomology, it examination was otherwise unremarkable. Investigation has only rarely been reported in the rheumatological showed plasma phosphorus 0.46-0.61 mmol/l (normal literature [11] [12] [13] [14] . Furthermore, most cases have been range 0.8-1.4); serum alkaline phosphatase (ALP) was published as single case histories shortly after patients 10.0-11.4 King-Armstrong ( KA) units, within the have appeared to be cured by surgery [3, 4] . Questions normal range (4) (5) (6) (7) (8) (9) (10) (11) (12) . Other normal findings included of diagnosis and management that have rarely been full blood count (FBC ), erythrocyte sedimentation rate addressed include (i) the extent and methods of search ( ESR), liver function enzymes, fecal fat excretion, renal for such tumours; (ii) the risk of relapse after surgery;
and bone biochemistry including calcium and para-(iii) the optimal drug treatment both in the initial stages thyroid hormone (PTH ), creatine phosphokinase and for long-term control; and (iv) the risk of other (CPK ), blood glucose and serum protein electrophorlong-term complications. Additionally, the repeated esis. There was no rheumatoid factor, anti-nuclear antireports of delays in diagnosis of up to 19 yr [4] suggest body, urinary Bence Jones protein, glycosuria or that the condition is poorly recognized. We therefore aminoaciduria. Radiographs showed osteopenia, healed briefly present the case histories of four patients who left distal ulnar and right subtrochanteric fractures and have been followed for up to 23 yr, to illustrate each of typical pseudofractures in two metacarpal bones. these problems.
Undecalcified transiliac bone biopsy revealed marked osteomalacia. Histological examination of the periscapular mass, removed incompletely under general anaesthetic, showed features similar to the original biopsy Two days after removal of the mass, the fasting serum She then began to relapse with associated hypophosphataemia (0.66-0.82 mmol/l ). In 1992 she underwent phosphorus had risen to 0.94 mmol/l. She was treated with 25- A 59-yr-old Caucasian woman was referred to the was detected after 1 yr of borderline-normal levels and within 3 months she was admitted acutely elsewhere metabolic unit in 1991 following a pathological fracture of her distal tibia and a 10-yr history of progressive with pyonephrosis, a staghorn renal calculus, a serum calcium of 2.77 mmol/l and a glomerular filtration rate height loss, spinal and diffuse limb pain for which she had seen numerous specialists. She had suffered a supraof 27 ml/min. Medication was stopped and she underwent a nephrectomy. Normal PTH levels were subcondylar elbow fracture following a fall 3 yr prior to referral. At the time she had been taking vitamin D 800 sequently demonstrated. Phosphate and alfacalcidol were restarted after she developed symptoms of osteo-IU daily for several months without benefit. She was unable to walk and complained bitterly of malacia associated with hypophosphataemia 3 months later. Her condition remains controlled.
diffuse limb pain and weakness. Examination revealed marked thoracic kyphosis, chest wall tenderness and proximal muscle weakness. Abnormal investigations Patient 2 A 60-yr-old woman was referred to the metabolic unit were serum phosphorus 0.4 mmol/l (normal range 0.8-1.2), ALP 1247 IU/l (normal range 100-280) and in 1979 with a 5-yr history of bilateral foot and diffuse left leg pain for which she had seen four physicians. The serum 1,25(OH ) 2 D 11.2-13.7 pg/ml (normal range 25-45). All other blood and urine investigations, as in previous year she had undergone a lumbar discectomy for sciatica with little subsequent relief. She then patient 1, were normal. Radiographs revealed osteopenia, bilateral pseudofractures of pubic rami, an developed bilateral hip, shoulder and rib pain with progressive weakness and difficulty in walking. Her diet impacted fracture of the left femoral neck and gross vertebral collapse ( Fig. 1) . Lumbar (L1-L4) bone denwas good, though she reported a 3 kg weight loss. Examination revealed a marked proximal myopathy and sity (BD) by dual X-ray absorptiometry (DXA) was 1.90 standard deviations (..) below an age-matched generalized bony tenderness but was otherwise unremarkable. There was no obvious tumour. Investigations mean and a technetium-99m-labelled MDP (99mTc-MDP) bone scan showed focal areas of tracer accumulashowed low plasma phosphorus (0.50-0.61 mmol/l ) and ALP 13-19 KA units (normal range 4-12), but other tion in the axial and appendicular skeleton. Undecalcified transiliac bone biopsy showed marked blood and urine investigations were normal, as in patient 1. Radiographs showed generalized osteopenia with osteomalacia. CT from head to pelvis failed to reveal a tumour. multiple rib and femoral neck pseudofractures. Undecalcified, transiliac bone biopsy showed severe She was treated initially with calcitriol 6 mg daily together with phosphate and calcium supplements for osteomalacia.
The diagnosis of acquired hypophosphataemic osteoover 3 months, during which time her pain and fatigue improved steadily; however, the circulating 1,25(OH ) 2 D malacia was made and she was treated initially with 10 mg alfacalcidol, 8 g Ossopan daily and Phosphate level did not rise above 25.4 pg/ml. She finally admitted with embarrassment to a swelling in the vulva which Sandoz q.d.s. Her symptoms improved within days. Within 1 month they had largely resolved. A metabolic she had had 'for years'. The soft-tissue mass, thought by the gynaecologists to be a Bartholin cyst, was excised balance study confirming the need for phosphate supplements during this phase has been reported previously and confirmed histologically as a haemangiopericytoma. Excision was thought at the time to be incomplete. [15] . Phosphate Sandoz was then reduced to t.d.s., alfacalcidol to 2 mg daily and later to 1 mg daily, and Nevertheless, serum 1,25(OH ) 2 D rose to 43.8 pg/ml despite a reduction in calcitriol dose to 4 mg daily, and she remained well with normophosphataemia for 2 yr. the right femur and also of L4 was confirmed; however, disseminated malignancy was also suspected because of his generally poor condition, weakness and widespread musculoskeletal pain associated with multiple truncal, rib and appendicular skeletal abnormalities reported on a 99mTc-MDP (methylene diphosphonate) scan (Fig. 2) . Investigations including serum protein electrophoresis, urinalysis for Bence Jones protein, liver function, prostate-specific antigen, abdominal ultrasound and CT were normal. Biopsy of bone marrow and iliac crest bone (decalcified ) failed to demonstrate malignancy. It was nevertheless concluded that the most likely diagnosis was metastatic cancer from an unknown primary tumour and he was treated with non-opioid analgesia and calcitonin for bone pain. Late in 1996 he returned to Iran. However, his weakness, mobility and pain slowly F. 1. Multiple thoracic vertebral fractures in a 59-yr-old woman with a 10-yr history consistent with a diagnosis of osteomalacia, ultimately diagnosed as oncogenic hypophosphataemic osteomalacia associated with a vulval haemangiopericytoma (patient 3).
the serum phosphate rose to 1.56 mmol/l. The relationship between her various biochemical indices at this time has been reported briefly [16 ] . Calcitriol was reduced further and finally stopped 5 months after surgery. However, within 1 month the ALP had risen and phosphate and 1,25(OH ) 2 D fallen to 0.7 mmol/l and 15 pg/ml respectively. Treatment with phosphate and calcitriol was recommenced and after 8 yr of followup she has remained well, although handicapped by kyphosis, on maintenance doses of Phosphate Sandoz t.d.s. and calcitriol 0.5 mg daily. Attempts to reduce the phosphate and calcitriol dose further have been associated with falls in serum phosphate and 1,25(OH ) 2 D. She has declined further surgery to her perineum.
Patient 4
A 61-yr-old Iranian man was referred to the metabolic unit in 1997 with a 5-yr history of progressively worsening widespread pain and weakness.
In Iran in 1995 he was shown to have typical radio- rheumatology consultation elsewhere. Paget's disease of deteriorated. He then returned to Britain and was sible in the fourth patient. Although acquired hypophosphataemic osteomalacia is a rare condition, these four referred to our unit in January 1997.
Owing to pain and weakness, he had become entirely cases illustrate the wholly disproportionate toll that its lack of recognition exacts. dependent on his family to complete all his domestic activities. He was cachectic, had a severe proximal Delay in diagnosis of OHO and the search for tumours myopathy, was unable to rise from a chair and could mobilize only with crutches. He had widespread vitiligo.
Despite over 100 cases of acquired hypophosphataemic osteomalacia and OHO in the literature [13] , the diagnoExamination was otherwise unremarkable and no tumour was found. Review of all medical records prior sis continues to be easily missed. Common to all our cases were consultation of a number of physicians, a to referral revealed raised ALP and persistent hypophosphataemia (0.39-0.69 mmol/l ). Abnormal investigadelay in correct diagnosis (3-12 yr) and prolonged morbidity. At worst, as with patient 4, and as previously tions in our unit were plasma phosphorus 0.36 mmol/l (normal range 0.7-1.5), ALP 345 IU/l (normal range reported [18] , patients may be mistakenly thought to have neoplasia with secondary skeletal metastases. In 35-115), plasma 25(OH )D 247 nmol/l (normal range ) and 1,25(OH ) 2 D <1 pmol/l (normal range the fourth case, the presence of Paget's disease deflected attention from the possibility of osteomalacia, although 25-150). Apart from evidence for Paget's disease of the right femur and L4 and general osteopenia, there were clearly the significance of hypophosphataemia was unrecognized and the possibility of osteomalacia was not no additional radiological signs, particularly no pseudofractures. Lumbar spine (L1-L4) BD by DXA was 3. 23 raised in the radiologist's bone scan report.
Having recognized hypophosphataemic osteomalacia, .. below an age-matched mean. An undecalcified transiliac bone biopsy showed severe osteomalacia with 100% the next question is the extent to which an associated tumour should be sought. As the first three cases illuscoverage of trabecular surfaces with broad osteoid tissue. Normal investigations included FBC, ESR, renal trate, tumours are often small, difficult to locate and in obscure areas. This is consistent with most other cases and bone biochemistry including plasma calcium and PTH, liver function, blood glucose and CPK. A search [3, 13] . In two of our patients the tumours were superficial (subcutaneous), though easy enough to overlook. for malignancy, including examination of faeces for occult blood, abdominal ultrasound and CT of the Tumours may predate the onset of osteomalacia or become evident after the diagnosis of hypophosphatpharynx and paranasal sinuses, was negative.
A diagnosis of acquired hypophosphataemic osteoaemic osteomalacia has been made [19] . The question remains, with regard to patient 4, as to whether, and malacia was made. He was treated with 4 mg calcitriol daily (reduced after 4 days to 3 mg), Phosphate Sandoz what kind of, investigations should be undertaken in a further search for a tumour. t.d.s. and, initially, 1500 mg calcium daily in divided doses. A noticeable improvement in muscle strength If the patient is unaware of any odd lump, and if a thorough clinical examination fails to identify one, then occurred within 3 weeks and was associated with normalization of his plasma phosphorus. Within 6 weeks he imaging studies should be done. The optimum imaging modality is not known but, as the majority of tumours was able to walk without using a stick. Plasma phosphorus and calcium stabilized in the normal range on 3 are in a limb and many in bone [13] , bone scintigraphy may be helpful [20] , though it will be difficult to interpret tablets Phosphate Sandoz and 2 mg calcitriol daily. After 4 months, his pains had virtually resolved and he had in the presence of osteomalacia and/or other bone diseases. Because tumours have prominent vasculature become freely mobile; however, he still had low back pain and an elevated ALP, presumed secondary to in approximately 50% of cases [13] , both scintigraphy with radiopharmaceuticals which have a prominent Paget's disease. This was treated with intravenous pamidronate before his return to Iran on long-term medicablood pool phase and angiography [21, 22] should also be considered. We would also recommend, as have tion. After 2 yr he remains well on a maintenance dose of calcitriol 0.75 mg daily.
others [3] , that investigation of the head and neck may be rewarding. There are no data comparing the performAll measurements of PTH and 1,25(OH ) 2 D in our hands have been carefully validated with respect to ance of CT and magnetic resonance imaging in a search for tumours. normal ranges and reproducibility [17] .
Management of acquired hypophosphataemic
Discussion osteomalacia and OHO Acquired hypophosphataemic osteomalacia will always Diagnosis of acquired hypophosphataemic osteomalacia requires recognition of the typical clinical and radiolorespond to large doses of vitamin D, or its potent derivatives and phosphate supplements [2, 5] . Although gical features of osteomalacia in association with hypophosphataemia [5] . Other conditions associated with it has been stated that the presence of an appropriate tumour prevents complete resolution of osteomalacia hypophosphataemia should be excluded ( Table 1 ). The diagnosis of OHO became evident in the first three [4] , it is clear from the present report that patients may be maintained in good health for years on medical patients after disclosure of a tumour which, after removal, resulted in improvement of symptoms and treatment alone. While the search for a tumour is important, as its complete resection commonly effects a biochemical indices. A diagnosis of OHO remains pos- cure [3] [4] [5] , it is also clear from our report that relapse ultimate colonic carcinoma is a possible candidate, and anecdotal reference has been made to hypophosphatmay be equally common if patients are followed for long enough. Moreover, these tumours are not encapsulaemia among patients with metastatic disease [3, 4] . Generally, long-term follow-up appears a prudent ated and complete resection may be problematical. Either way, it is clear that big doses of calcitriol or measure. alfacalcidol and phosphate supplements rapidly relieve Long-term pharmacological management symptoms in the early stages [3, 4, 23] and will speed recovery whether or not a tumour has been successfully All four of these cases illustrate that pharmacological therapy may be necessary in the long term. Experience resected. Metabolic balance studies have shown the additional effect of calcium supplements in the first [4] [5] [6] from the present cases, other cases in our experience ( T.C.B. Stamp, unpublished findings) and those in the months of healing [2] . Our experience suggests that only when patients have recovered clinically should calcitriol literature suggests patients can be maintained on 0.5-1 mg calcitriol or 2-3 mg alfacalcidol together with be discontinued to determine whether a cure has indeed been effected. a supplement of 1500 mg phosphorus daily. We are unaware of any studies which suggest an optimal diurnal Relapse of osteomalacia timing of supplementation. The importance of regular renal monitoring in order to forestall progressive calciWhile reported 'cures' suggest that treatment be safely discontinued after clinical and biochemical recovery fication is only too well illustrated by the first case, although a purely infective aetiology cannot be excluded. following tumour resection, it is clear from the present report that the frequency of relapse has been inadFinally, 'tertiary' hyperparathyroidism has been stated to occur in 5% of OHO cases [4] . This may be an equately emphasized in the literature. Incomplete resection, as in our first and third patients, is one obvious underestimate as it was observed in two of an original series of nine patients with acquired hypophosphataemia reason. Multicentric tumours are another possibility [20, 24, 25] . The cause of relapse in our second patient, 4 yr
[5]. Its aetiology has been debated [4, 14, 26, 27] , though it may simply be a complication of long-term after treatment withdrawal, is obscure as CT did not identify a tumour recurrence at the original site. Her phosphate supplementation, reducing calcium levels and inducing parathyroid hyperplasia, as in X-linked hypo-
